CStone Pharmaceuticals (HKG:2616) said its Hong Kong-listed shares have been added to the eligible securities list for southbound trading under Stock Connect, effective Sept. 7, according to a same-day Hong Kong bourse filing.
Shares of the biopharmaceutical company fell nearly 1% in recent trade.